Compare Edwards Lifesciences Corporation Common Stock (EW) vs Freshworks Inc (FRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Freshworks Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Freshworks Inc trades at $13.75 (market cap $3.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 13.6× Freshworks Inc's market cap, and Freshworks Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | FRSH | |
|---|---|---|
Market Cap | $48.56B | $3.56B |
Volume | 6,520,488 | 9,066,454 |
Sector | Health | Technology |
52-Week High | $95.18 | $13.92 |
52-Week Low | $72.65 | $6.88 |
Enterprise Value | $45.01B | $2.93B |
Typical Hold Time | — | 39 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Freshworks (FRSH) trades at $13.60, down 1.16% today, with strong technical momentum showing bullish moving averages despite overbought RSI readings. The company achieved its first GAAP profitability in Q2 2026 with revenue growth of 16% year-over-year, while maintaining impressive gross margins of 84.96%. Recent developments include FedRAMP certification progress and leadership in Gartner's ITSM Magic Quadrant.
The outlook remains positive with analyst consensus at $14.60 target (7.4% upside) and balanced buy/hold ratings. Key opportunities include AI monetization and enterprise expansion, while risks involve competitive SaaS pressures and execution on growth targets. The stock presents a compelling value proposition with improving profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →
